Copyright
©The Author(s) 2025.
World J Clin Oncol. Apr 24, 2025; 16(4): 100729
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.100729
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.100729
Figure 1 Multidisciplinary tumor board vs non-multidisciplinary tumor board.
A: Overall survival; B: Disease-free survival. MDTB: Multidisciplinary tumor board.
Figure 2 Multidisciplinary tumor board vs non-multidisciplinary tumor board.
These results indicate patients that were within the University of California, San Francisco (UCSF) criteria. A: Overall survival; B: Disease-free survival. MDTB: Multidisciplinary tumor board.
Figure 3 Multidisciplinary tumor board vs non-multidisciplinary tumor board.
These results indicate patients that exceeded the University of California, San Francisco (UCSF) criteria. A: Overall survival; B: Disease-free survival. MDTB: Multidisciplinary tumor board.
- Citation: Zhang L, Yang J, Li JJ, Chen CY, Wang XD, Xie Y, Jiang WT. Multidisciplinary tumor board is associated with improved survival in patients with hepatocellular carcinoma after liver transplantation. World J Clin Oncol 2025; 16(4): 100729
- URL: https://www.wjgnet.com/2218-4333/full/v16/i4/100729.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i4.100729